Dr. Arunesh P K

MBBS ( MMC , Chennai )
MD DERMATOLOGY AND VENEREOLOGY ( PGY3 , RML, DELHI )

[@RML Hospital, New Delhi @RMLHDelhi]

The Department of Dermatology held the annual appreciation awards for service and competence, graced by Director and Medical Superintendent:-

1. Best SR, Dr. Gaby L
2. Best PG, Dr. Arunesh PK
3. Best Ministerial staff, Sh. Shiv

[Dr. Arunesh P K @arunesh1998]

Now a days, there is a surge of fake hair experts without qualification giving consultations online.

Personal regrowth story ≠ universal cure

One size doesn’t fit all.

Hair loss has many causes.

One success story cannot treat every diagnosis/patients.
#Haircare
#DrArunesh

[Dr. Arunesh P K @arunesh1998]

Doxycycline PEP

Effective against chlamydia, syphilis.

Variable protection against gonorrhea.

No protection against viral STI.

Not a substitute for condoms.

#DoxyPEP
#STIPrevention
#SexualHealth
#STIAwareness
#HIVPrevention
#MSMHealth
#Drarunesh

[Dr. Arunesh P K @arunesh1998]

Many people are getting scammed by fake or commercial hair clinics selling procedure packages.

Treat the disease. Don’t get packaged.

#Drarunesh #dermatology #hair #patientawareness #Scam

[Dr. Arunesh P K @arunesh1998]

HIV is preventable and treatable.
Timely treatment allow a normal life expectancy.
Let's break the stigma.
#HIVIndia #KnowYourStatusIndia #Stigmafree #DrArunesh #venereologist
@NACOINDIA

[Dr. Arunesh P K @arunesh1998]

Had an unprotected sex?
Don't live with fear.
Know your status. Protect your future.
#HIVIndia #KnowYourStatusIndia #Stigmafree
#DrArunesh #venereologist @NACOINDIA

[Dr. Arunesh P K @arunesh1998]

@Rheumat_Aravind Even in ayushman bharat health scheme, it is not included. It should start from government level.

[Dr. Arunesh P K @arunesh1998]

@Meesho_Official @meesho_support @snapdeal Many whitening creams like Elosone HT and Skinshine which are under SCHEDULE H are available in your platforms. Many patients are using these creams and presenting to OPD with irreversible skin damage. kindly look into it. #steroidabuse

[Dr. Arunesh P K @arunesh1998]

Biotin supplementation does nothing for hair/skin/nails unless there is true deficiency.

Biotin deficiency is rare.

Don't fall for influencers and don't waste money.

https://t.co/xoXAArlcxc

#dermatology #Hair #hairloss #influencer #DoctorX #india

[Dr. Arunesh P K @arunesh1998]

It's good to know the median time to relapse after biologics in Psoriasis management.

Relapse is the rule post treatment discontinuation.

https://t.co/JNH5y8uzkj
#Psoriasis #dermatology
@jidinnovations

[Dr. Arunesh P K @arunesh1998]

@DealsDhamaka @pharmeasyapp Not only pharmeasy, it is happening in most of the online pharmacy platforms.
Pushing generics despite denying that.
Same happened to me with @Truemedsindia.
They changed the brands without informing me.

Pushing ayurvedic based juices or supplements after orders.
#scam

[Dr. Arunesh P K @arunesh1998]

@RichardOkeke @DrAkhilX Published in JAAD. No benefit unless there is deficiency.

[Dr. Arunesh P K @arunesh1998]

💉 Tildrakizumab — IL-23 inhibitor officially launched in India
Marketed by Sun Pharma.
Dose: 100 mg at week 0 & 4, then every 12 weeks.
💰 MRP: 90,000 | Patient price: approx. 51,500. / 100mg
A new biologic option for moderate–severe plaque psoriasis.

[Dr. Arunesh P K @arunesh1998]

extended use approvals:

6. Dupilumab (Dupinext)

Approved for Chronic Spontaneous Urticaria and Bullous Pemphigoid.

7. Ruxolitinib cream

Approved for moderate atopic dermatitis ≥ 2 years.

8. Roflumilast Topical Foam 0.3%

Approved for plaque psoriasis.

[Dr. Arunesh P K @arunesh1998]

#Dermatology | 2025 FDA Approvals
New FDA-approved drugs till now in 2025

1. Remibrutinib (Rhapsido) – Approved Sep 30, 2025

Indication: To treat chronic spontaneous urticaria in adults who remain symptomatic despite H1 antihistamine treatment.
MOA: Oral BTK inhibitor with rapid antihistamine-independent control of hives.

2. Delgocitinib (Anzupgo) – Approved Jul 23, 2025

Indication: To treat moderate-to-severe chronic hand eczema when topical corticosteroids are not advisable or produce an inadequate response.

MOA: topical pan-JAK inhibitor cream

3. Sebetralstat (Ekterly) – Approved Jul 3, 2025

Indication: To treat acute attacks of hereditary angioedema

MOA: Oral, on-demand plasma kallikrein inhibitor

4. Garadacimab-gxii (Andembry) – Approved Jun 16, 2025

Indication: To prevent attacks of hereditary angioedema

MOA: Monoclonal antibody targeting FXIIa

5. Mirdametinib (Gomekli)

Indication: To treat neurofibromatosis type 1 who have symptomatic plexiform neurofibromas not amenable to complete resection

MOA: MEK1/2 inhibitor
#FDA #DrugApproval #Dermatologyresearch #Handeczema #hereditaryangioedema #urticaria #NF

[Dr. Arunesh P K @arunesh1998]

@drsunita02 In Tamilnadu, government passed order for the same in 2023. But i don't know whether they are following or not.

TN tweaks norms, directs hotels to provide accommodation for drivers | India News - Business Standard https://t.co/FqOuVOai66

[Dr. Arunesh P K @arunesh1998]

@spinesurgeon Quality of life is an important parameter. It is ignored most of the times.

[Dr. Arunesh P K @arunesh1998]

@venkat_fin9 Still, they are electing nitish kumar despite not getting proper jobs, proper healthcare and infra-structure. If you ask any doctor working in government hospital in delhi, many patients are coming from with Bihar without proper treatment and mismanagement.